Iovance Biotherapeutics, Inc. Gains 27.42%
Tue, Feb 25, 2020 at 05:30 PM
Iovance Biotherapeutics, Inc. (IOVA:NASDAQ) jumped higher at $31.46, representing a gain of 27.4%. The stock got featured on our News Catalysts scanner on Wed 19 Feb 20 at 07:37 AM in the 'EARNINGS' category. From Mon 03 Feb 20, the stock recorded 78.57% Up Days and 66.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Iovance Biotherapeutics, Inc. (IOVA:NASDAQ)
Lion Biotechnologies Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.
Top 10 Gainers:
- Spherix Incorporated (SPEX:NASDAQ), 136.89%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 40.06%
- Iovance Biotherapeutics, Inc. (IOVA:NASDAQ), 27.42%
- Jumei International Holding Limited (JMEI:NYSE), 26.18%
- Summer Infant, Inc. (SUMR:NASDAQ), 22.42%
- Arlo Technologies, Inc. (ARLO:NYSE), 20.85%
- Endologix, Inc. (ELGX:NASDAQ), 20.72%
- VivoPower International PLC (VVPR:NASDAQ), 20.69%
- Tarena International, Inc. (TEDU:NASDAQ), 19.49%
- VelocityShares Daily 2x VIX Short-Term ETN (TVIX:NASDAQ), 19.16%